KRChoksey is bearish on Dishman Pharma and has recommended reduce rating on the stock with a target of Rs 61 in its February 13, 2012 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!